The U.S. Court of Appeals for the Federal Circuit invalidated on Friday the patent for the once-a-week version of Merck's blockbuster osteoporosis drug Fosamax. Under the ruling, generic competition ...
Mar. 23 -- WEDNESDAY, Feb. 6 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first generic equivalents of Fosamax (alendronate sodium), Merck & Co.'s osteoporosis drug. In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results